Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P040021/S061

Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valves

ABBOTT MEDICAL · Decision date Jun 22, 2026

FDA DECISIONP040021/S061

What did the FDA approve?

FDA records P040021/S061 as a supplement to PMA P040021, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jun 22, 2026.

FDA approval order statement

Approval for a next generation of the Epic family of tissue heart valves, collectively referred to as Epic Elite/G3. The changes to the Epic Elite/G3 valves include the addition of an expansion feature on the stent to facilitate future Valve-in-Valve (ViV) procedures, a change in stent material to an equivalent material from the same supplier, and minor marking and suture changes.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Jun 22, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P040021/S061
Regulatory pathway
PMA supplement
Product code
LWR
Decision code
APPR
Decision date
Jun 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: heart-valve, non-allograft tissue.

Product code
LWR
FDA device class
3

For the original device and its historical approval scope, see PMA P040021. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P040021 · Original PMA

    SJM BIOCOR VALVE / SJM BIOCOR SUPRA VALVE

  2. P040021/S059 · Related supplement

    Epic Plus Stented Tissue Valve; Epic Max Stented Tissue Valve

  3. P040021/S060 · Related supplement

    Epic, Epic Supra, Epic Plus, Epic Plus Supra and Epic Max Stented Tissue Valve

  4. P040021/S061 received

    Application receipt date recorded by FDA.

  5. P040021/S061 · FDA decision

    Normal 180 Day Track

  6. P040021/S062 · Related supplement

    Epic, Epic Supra, Epic Plus, Epic Plus Supra and Epic Max, Epic Elite, and Epic Supra G3 Stented Tissue Valves

  7. P040021/S063 · Related supplement

    Epic Plus, Epic Plus Supra, Epic Max, Epic Elite, Epic Supra G3 Tissue Heart Valves

Timeline entries are records held by MedtechLedger for P040021. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P040021

Explore the linked device profile

Other records with product code LWR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records